Press Releases

Date Title  
Lantheus Holdings Announces Submission of Drug Master File for NM-01 in the U.S.
NORTH BILLERICA, Mass. --(BUSINESS WIRE)--Jan. 12, 2021-- Lantheus Holdings, Inc. (NASDAQ: LNTH) ( Lantheus ), the parent company of Lantheus Medical Imaging, Inc. and Progenics Pharmaceuticals, Inc. , and a global leader in the development, manufacture and commercialization of innovative